You are here

Home › 药物研发

药物研发

蛋白质晶体和X射线晶体学

药物研发

医学中，生物技术、药理和药物研发是研发设计药物的过程。近代，大多数的药物研发不是通过从传统的疗法中识别有效成分就是偶然发现。一种所谓“合理药物设计”的新方法，了解了如何在生理和分子级别上控制疾病和感染，并且基于这种知识目标特定实体。鉴于这种重要性，理学公司已发展为大分子和小分子结构检测的单晶衍射的最前列。我们的产品范围包括自动结晶化、通过筛选晶体衍射观测晶体、对于三维结构精修和图像处理软件的高分辨率数据收集系统。

X-ray Diffraction systems
 
XtaLAB Synergy-R   XtaLAB Synergy-R
Single crystal diffraction system with MicroMax-007 HF microfocus rotating anode generator		   XtaLAB Synergy-S   XtaLAB Synergy-S
Fast, flexible system with the latest generation sources and HPC detectors, perfect for any crystallography lab.
 
XtaLAB Synergy Custom   XtaLAB Synergy Custom
Single crystal diffraction system with custom enclosure and flexibility for easy integration of accessory components		    

Rigaku Small Molecule products
Rigaku Chem ident
Rigaku Elemental Analysis products
Rigaku Materials Analysis products
Rigaku Semiconductor products
Rigaku Life Sciences products
Rigaku Vacuum products
Rigaku detectors
Rigaku optics
X-ray Sources

In the spotlight

ResQ CQL
ResQ CQL

The ResQ CQL analyzer offers first responders, border protection and law enforcement an advanced method for identifying potential chemical threats in an improved tactical form factor, thus improving functionality particularly in high stress environments.
>> See more

Copyright © 2019 — Rigaku Corporation and its Global Subsidiaries. All Rights Reserved.